Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Melero, I. (Ignacio) | - |
| dc.creator | Martinez-Forero, I. (Iván) | - |
| dc.creator | Dubrot, J. (Juan) | - |
| dc.creator | Suarez, N. (Natalia) | - |
| dc.creator | Palazon, A. (Asís) | - |
| dc.creator | Chen, L. (Lieping) | - |
| dc.date.accessioned | 2012-04-24T15:56:58Z | - |
| dc.date.available | 2012-04-24T15:56:58Z | - |
| dc.date.issued | 2009 | - |
| dc.identifier.citation | Melero I, Martinez-Forero I, Dubrot J, Suarez N, Palazon A, Chen L. Palettes of vaccines and immunostimulatory monoclonal antibodies for combination. Clin Cancer Res 2009 Mar 1;15(5):1507-1509. | es_ES |
| dc.identifier.issn | 1557-3265 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/21780 | - |
| dc.description.abstract | Various monoclonal antibodies (mAb) target immune system molecules to enhance immunity by costimulating T cells (i.e., CD137, OX40, CD40, GITR) or interfering in coinhibitory signals (i.e., CTLA-4, PD-1). These powerful agents can be guided by cancer vaccines to enhance immunity against tumor but not self tissues. Clinically powerful therapeutic synergies are at hand. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | American Association for Cancer Research | es_ES |
| dc.rights | info:eu-repo/semantics/closedAccess | - |
| dc.subject | Antibodies, Monoclonal/therapeutic use | es_ES |
| dc.subject | Cancer Vaccines/therapeutic use | es_ES |
| dc.subject | Neoplasms/therapy | es_ES |
| dc.title | Palettes of vaccines and immunostimulatory monoclonal antibodies for combination | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherversion | http://clincancerres.aacrjournals.org/content/15/5/1507 | es_ES |
| dc.type.driver | info:eu-repo/semantics/article | es_ES |
Files in This Item:
There are no files associated with this item.
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
